Conshohocken, PA (PRWEB) November 26, 2013
Diabetes Care recently published an article on a study that compared the efficiency of nonmydriatic fundus photography (NMFP) to that of nonmydriatic ultra-widefield retinal imaging (UWFI) in a diabetic retinopathy ocular telehealth program. Estenda Solutions’ CDMP (Comprehensive Disease Management Program) software and the Retinopathy module were used in the data collection and reporting of the two groups of diabetes patients that were imaged and evaluated for diabetic retinopathy and diabetic macular edema.
NMFP was used to evaluate 1,633 patients with diabetes, while UWFI was used with a group of 2,170. There were no significant statistical differences regarding age, disease duration, gender, ethnicity, or insulin use, between the two groups. The study found that UWFI had a lower ungradable rate than NMFP and it proved better at identifying patients with diabetic retinopathy and vision-threatening diabetic retinopathy.
Estenda believes these positive findings, further justify the investment in continuing to expand its existing CDMP software to integrate with advanced UWFI cameras and more advanced technology, further aiding the evaluation of diabetic retinopathy in patients with diabetes mellitus.
About Estenda: Estenda Solutions is an ISO 9001/13485 certified, global project consulting and custom software development firm, focused on bringing innovative healthcare initiatives from concept to reality. Estenda Solutions collaborates with healthcare providers, research professionals, and industry to create innovative solutions. Estenda’s goals are to continuously provide tools to enable better patient care and self- management. Estenda has a rich history of work in chronic disease management, patient-centered medical home solutions, home monitoring, public health, telemedicine and clinical decision-support designing, and developing intelligent, integrated patient care and management solutions. For more information, visit http://www.estenda.com.